| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3638 |
| Trial ID | NCT06101381 |
| Disease | Acute Lymphoblastic Leukemia | Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Not Recruiting |
| Title | CD19-directed CAR-T Cell Therapy for Refractory or Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma: a Multicenter Phase I/II Trial. |
| Year | 2023 |
| Country | Brazil |
| Company sponsor | University of Sao Paulo |
| Other ID(s) | HEMO-02-CART |
| Vector information | |||
|
|||
| Cohort1: ALL | |||||||||||
|
|||||||||||
| Cohort2: NHL | |||||||||||
|
|||||||||||